{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:28:48Z","timestamp":1747153728639,"version":"3.40.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00520-023-08056-z","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T21:01:52Z","timestamp":1695934912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of treatment experience on patient knowledge of colony-stimulating factors among patients receiving cancer chemotherapy: evidence from S1415CD\u2014a large pragmatic trial"],"prefix":"10.1007","volume":"31","author":[{"given":"Gary H.","family":"Lyman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aasthaa","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean D.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn B.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn L.","family":"Hershman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Lad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5972-8280","authenticated-orcid":false,"given":"Scott D.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"issue":"8","key":"8056_CR1","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1200\/JCO.2000.18.8.1764","volume":"18","author":"G Swanson","year":"2000","unstructured":"Swanson G, Bergstrom K, Stump E, Miyahara T, Herfindal ET (2000) Growth factor usage patterns and outcomes in the community setting: collection through a practice-based computerized clinical information system. J Clin Oncol 18(8):1764\u20131770. https:\/\/doi.org\/10.1200\/JCO.2000.18.8.1764","journal-title":"J Clin Oncol"},{"issue":"4","key":"8056_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jtumed.2020.06.001","volume":"15","author":"AA Alhifany","year":"2020","unstructured":"Alhifany AA, McAllister MW (2020) Assessment of granulocyte-colony stimulating factors use at a community-based teaching hospital and compliance with National Comprehensive Cancer Network guidelines. J Taibah Univ Med Sci 15(4):321\u2013324. https:\/\/doi.org\/10.1016\/j.jtumed.2020.06.001","journal-title":"J Taibah Univ Med Sci"},{"issue":"6","key":"8056_CR3","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s00520-017-3572-4","volume":"25","author":"C Bokemeyer","year":"2017","unstructured":"Bokemeyer C, Gascon P, Aapro M, Ludwig H, Boccadoro M, Denhaerynck K et al (2017) Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF study. Support Care Cancer 25(6):1819\u20131828. https:\/\/doi.org\/10.1007\/s00520-017-3572-4","journal-title":"Support Care Cancer"},{"issue":"9","key":"8056_CR4","first-page":"678","volume":"16","author":"SD Ramsey","year":"2010","unstructured":"Ramsey SD, McCune JS, Blough DK, McDermott CL, Clarke L, Malin JL et al (2010) Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancer. Am J Manag Care 16(9):678\u2013686","journal-title":"Am J Manag Care"},{"issue":"5","key":"8056_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2217\/cer-2017-0005","volume":"6","author":"A Bansal","year":"2017","unstructured":"Bansal A, Sullivan SD, Hershman DL, Lyman GH, Barlow WE, McCune JS et al (2017) A stakeholder-informed randomized, controlled comparative effectiveness study of an order prescribing intervention to improve colony stimulating factor use for cancer patients receiving myelosuppressive chemotherapy: the TrACER study. J Comp Eff Res 6(5):461\u2013470. https:\/\/doi.org\/10.2217\/cer-2017-0005","journal-title":"J Comp Eff Res"},{"issue":"1","key":"8056_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12874-019-0764-2","volume":"19","author":"S Barger","year":"2019","unstructured":"Barger S, Sullivan SD, Bell-Brown A, Bott B, Ciccarella AM, Golenski J et al (2019) Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care. BMC Med Res Methodol 19(1):119. https:\/\/doi.org\/10.1186\/s12874-019-0764-2","journal-title":"BMC Med Res Methodol"},{"key":"8056_CR7","unstructured":"National Institutes of Health (2021) National Cancer Institute Community Oncology Research Program (NCORP). https:\/\/ncorp.cancer.gov\/ Accessed 26 Oct 2021"},{"issue":"16_suppl","key":"8056_CR8","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1200\/JCO.2022.40.16_suppl.1518","volume":"40","author":"DL Hershman","year":"2022","unstructured":"Hershman DL, Bansal A, Sullivan SD, Lyman GH, Barlow WE, Arnold KB et al (2022) A pragmatic cluster-randomized trial of a standing physician order entry intervention for colony stimulating factor use among patients at intermediate risk for febrile neutropenia (SWOG S1415CD). J Clin Oncol 40(16_suppl):1518. https:\/\/doi.org\/10.1200\/JCO.2022.40.16_suppl.1518","journal-title":"J Clin Oncol"},{"issue":"16_suppl","key":"8056_CR9","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1200\/JCO.2022.40.16_suppl.1525","volume":"40","author":"SD Ramsey","year":"2022","unstructured":"Ramsey SD, Bansal A, Sullivan SD, Lyman GH, Barlow WE, Arnold KB et al (2022) A pragmatic cluster-randomized trial of a computerized clinical decision support system to improve colony stimulating factor prescribing for patients with cancer receiving myelosuppressive chemotherapy (SWOG S1415CD). J Clin Oncol 40(16_suppl):1525. https:\/\/doi.org\/10.1200\/JCO.2022.40.16_suppl.1525","journal-title":"J Clin Oncol"},{"issue":"2","key":"8056_CR10","doi-asserted-by":"publisher","first-page":"e0228571","DOI":"10.1371\/journal.pone.0228571","volume":"15","author":"A Lively","year":"2020","unstructured":"Lively A, Minard LV, Scott S, Deal H, Lambourne T, Giffin J (2020) Exploring the perspectives of healthcare professionals in delivering optimal oncology medication education. PLoS One 15(2):e0228571. https:\/\/doi.org\/10.1371\/journal.pone.0228571","journal-title":"PLoS One"},{"issue":"2","key":"8056_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s13187-021-01957-9","volume":"36","author":"DM Tyson","year":"2021","unstructured":"Tyson DM, Chavez MN, Lubrano B, Lake P, Gutierrez A, Marshall VK et al (2021) Understanding cancer survivors' educational needs about prescription opioid medications: implications for cancer education and health literacy. J Cancer Educ 36(2):215\u2013224. https:\/\/doi.org\/10.1007\/s13187-021-01957-9","journal-title":"J Cancer Educ"},{"key":"8056_CR12","unstructured":"Neulasta Onpro (2019) Neulasta Onpro Commercial #2. USA: Youtube. Uploaded by ZandZ Mom,\u00a0https:\/\/www.youtube.com\/watch?v=Qv3BSnumcqg. Accessed 26 Oct 2021"},{"key":"8056_CR13","unstructured":"Neulasta (2019) I'm Ready. USA: Youtube; 2006. p. 1:00. Uploaded by Affinity for the Impossible, https:\/\/www.youtube.com\/watch?v=IB8wj5SX_f8. Accessed 26 Oct 2021"},{"key":"8056_CR14","unstructured":"Amgen (2018) Neulasta Onpro TV Spot, 'Rather be home- Onpro'.\u00a0https:\/\/www.ispot.tv\/ad\/wx59\/neulasta-onpro-rather-be-home-onpro. Accessed 26 Oct 2021"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-08056-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-08056-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-08056-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T09:10:11Z","timestamp":1697533811000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-08056-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["8056"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-08056-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"assertion":[{"value":"25 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The TrACER trial was approved by institutional review boards at Fred Hutchinson Cancer Center in Seattle, WA (IR#8428) and at each of the 45 NCORP recruiting sites in the USA and Puerto Rico. A complete list of sites and their individual recruiting locations is available on : . All procedures performed were in accordance with the ethical standards of the approving institutional review board and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Author S.R. reported having consulting or advisory roles with Bayer Corporation, GRAIL, Biovica, Flatiron Health, and Genentech and receiving research funding not related to this work from Genentech\/Roche and Bayer Corporation. Author G.L. reported receiving research grants not related to this work from Amgen (to institution) and personal fees from Sandoz, G1 Therapeutics, Partners Healthcare, BeyondSpring, Squibb, Merck, Jazz Pharmaceuticals, Samsung, Seattle Genetics, and Fresenius outside the submitted work. Other authors report no other relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors or Methodology Committee, nor does it reflect the views or policies of the National Cancer Institute, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}],"article-number":"598"}}